190 related articles for article (PubMed ID: 31566785)
1. Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review.
Blake SC; Murrell DF
Pediatr Dermatol; 2019 Nov; 36(6):843-853. PubMed ID: 31566785
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin for atopic dermatitis in children.
Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
[TBL] [Abstract][Full Text] [Related]
3. [Cyclosporin A in atopic dermatitis].
Cordero Miranda MA; Casas Becerra B; Reyes Ruiz NI; Avila Castañón L; del Río Navarro BE; Sienra Monge JJ
Rev Alerg Mex; 2002; 49(4):129-34. PubMed ID: 12374046
[TBL] [Abstract][Full Text] [Related]
4. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
[TBL] [Abstract][Full Text] [Related]
5. Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA;
G Ital Dermatol Venereol; 2014 Oct; 149(5):607-25. PubMed ID: 25213388
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
[TBL] [Abstract][Full Text] [Related]
7. Update on systemic therapies for atopic dermatitis.
Denby KS; Beck LA
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
[TBL] [Abstract][Full Text] [Related]
8. Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis.
Blasco Morente G; Tercedor Sánchez J; Garrido Colmenero C; Martínez García E; Molina-Carballo A
Pediatr Dermatol; 2015; 32(2):237-9. PubMed ID: 24330027
[TBL] [Abstract][Full Text] [Related]
9. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
11. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
12. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
Czech W; Bräutigam M; Weidinger G; Schöpf E
J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection.
Gnarra M; De Simone C; Garcovich M; Garcovich S
Pediatr Dermatol; 2017 May; 34(3):374-376. PubMed ID: 28382768
[TBL] [Abstract][Full Text] [Related]
14. Can three-times-a-day cyclosporine Neoral avoid cyclosporine toxicity in renal transplant recipients? A pharmacokinetic study.
Swart N; Botha J; Tandon V; Michaels P; Pontin AR; Halkett J; Pascoe MD; Kahn D
Transplant Proc; 2001; 33(7-8):3140-1. PubMed ID: 11750349
[No Abstract] [Full Text] [Related]
15. A Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice.
Daguzé J; Aubert H; Bernier C; Gaultier A; Nguyen JM; Stalder JF; Barbarot S
Acta Derm Venereol; 2017 Aug; 97(8):955-956. PubMed ID: 28448098
[No Abstract] [Full Text] [Related]
16. Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).
Couselo-Rodríguez C; Batalla A; Carrascosa JM; Chicharro P; González-Quesada A; de la Cueva P; Giménez-Arnau AM; Gilaberte Y; Rodríguez-Serna M; Montero-Vilchez T; Ruiz-Villaverde R; Elosua-González M; Silvestre-Salvador JF; Munera-Campos M; Sánchez-Pérez J; Carretero G; Mauleón-Fernández C; Curto-Barredo L; Ballano-Ruiz A; Botella-Estrada R; Arias-Santiago S; Navarro-Triviño FJ; Roustan-Gullón G; Betlloch I; Del Alcázar E; Abalde-Pintos MT; Suárez-Perez J; García-Doval I; Descalzo MÁ; Flórez Á
Actas Dermosifiliogr; 2024 Apr; 115(4):341-346. PubMed ID: 37482292
[TBL] [Abstract][Full Text] [Related]
17. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
[TBL] [Abstract][Full Text] [Related]
18. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels.
Heydendael VM; Spuls PI; Ten Berge IJ; Opmeer BC; Bos JD; de Rie MA
Br J Dermatol; 2002 Jul; 147(1):122-9. PubMed ID: 12100194
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
